Ultrasound-guided Lumbar Periradicular Injection: a Non Irradiating Infiltration Technique
Unknown statusNot applicableNCT03453775
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
We propose here to evaluate the precision of lumbar periradicular infiltration performed under a transverse ultrasound approach by performing a fluoroscopic control once the needle in the desired position. The effectiveness of the technique will be assessed by measuring different pain and disability scores at four weeks post-infiltration: the Visual analogue pain Scale score, the DN4 score, and the Oswestry disability score (ODI); The decrease in irradiation received will be collected, compared to that of the conventional fluoroscopic technique.
Study details
- Official title
- Ultrasound-guided Lumbar Periradicular Injection: Effectiveness and Benefits of a Non Irradiating Infiltration Technique. A Randomized Controlled Trial
- Conditions
- Low Back Pain
- Sciatica
- Disc, Herniated
- Foraminal Hernia
- Lumbar Foraminal Stenosis
- Chronic Low Back Pain
- Pain, Chronic
- Injection Site Infiltration
- Interventions
- Device: Ultrasound guided periradicular lumbar infiltration
- Device: Fluoroscopy guided periradicular lumbar infiltration
- Sponsor
- Université Libre de Bruxelles
- Start date
- 2018-02-27
- Primary completion
- 2018-04-30
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * neurology, neurosurgery, physical medicine, algology consultation * over the age of 18 * Radiculalgia in the territory corresponding to the root lesion * Symptomatology inferior to two months. * Imaging (CT scan or MRI) or electromyographic study with evidence (foraminal disc herniation or foraminal stenosis) of the irritation or the causal compression of the radicular symptomatology Exclusion Criteria: * allergy to any of the constituents of the infiltrated product, or to the contrast medium * unstable medical condition: cardiac, respiratory, endocrine (uncontrolled diabetes) * inability to put himself in a prone position * depression: HADS score equal to or greater than 11. * root lesion caused by an accident at work, a tumoral or infectious causal process. * local infection (cutaneous, perimedullary / spinal) or systemic * coagulopathy (platelets \<50000 / mm3, Prothrombin time \<60%, INTernational normalized ratio\> 1.5), anticoagulant or antiplatelet therapy treatment other than aspirin * Lumbar surgical history * history of foraminal or perimedullary infiltration of less than 6 months * symptoms older than two months * pregnant woman
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03453775